Bita Fakhri, MD, MPH

Stanford Cancer Institute, Stanford University

Poster(s):

• 1110 - Clinical Profiles of Chronic Lymphocytic Leukemia Patients with SF3B1 Mutations: A Single-Institution Study

• 1707 - Evaluating CLL/SLL Clinical Trials: A Participation-to-Prevalence Analysis Using Institutional and SEER Data from 2012-2024

• 1803 - Real-world Treatment Outcomes among Patients with High-Risk CLL/SLL Receiving Venetoclax-Based Therapy in 1L or 2L: An Updated International Study